Patel Naimish
Insider CIK 2021679 · CRSP Chief Medical Officer · AGMB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-10-26 | 2026-10-28 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-10-26 | 2026-10-28 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGMB AgomAb Therapeutics NV | A Award deriv | 2026-09-11 | 2026-09-15 | 56,328 | — | $0 | 56,328 | SEC↗ |
| AGMB AgomAb Therapeutics NV | A Award deriv | 2026-09-11 | 2026-09-15 | 56,328 | — | $0 | 56,328 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-05-29 | 2026-06-02 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-05-29 | 2026-06-01 | 3,786 | $55.62 | $210.6K | 19,357 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-05-28 | 2026-06-01 | 10,000 | — | $0 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-05-28 | 2026-06-01 | 10,000 | — | $0 | 23,143 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 38,499 | — | $0 | 38,499 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-16 | 2026-03-17 | 3,150 | $48.26 | $152.0K | 13,143 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-14 | 2026-03-17 | 8,125 | — | $0 | 24,375 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-14 | 2026-03-17 | 8,125 | — | $0 | 16,293 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-10-03 | 2025-10-03 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-05-30 | 2025-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-05-29 | 2025-05-30 | 3,932 | $35.94 | $141.3K | 6,068 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-05-28 | 2025-05-30 | 10,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-05-28 | 2025-05-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2025-04-03 | 2026-01-27 | 1,508 | $32.96 | $49.7K | 1,508 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 32,500 | — | $0 | 32,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 46,667 | — | $0 | 46,667 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-10-16 | 2024-10-18 | 18,333 | — | $0 | 18,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-05-28 | 2024-05-29 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-05-28 | 2024-05-29 | 40,000 | — | $0 | 40,000 | SEC↗ |